Published in Diabetes on January 01, 1980
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
One hundred pancreas transplants at a single institution. Ann Surg (1984) 1.20
Recent experience with 89 pancreas transplants at a single institution. Diabetologia (1984) 0.96
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation. J Transplant (2011) 0.85
Pancreatic autotransplantation in chronic pancreatitis. World J Surg (2003) 0.83
Long-term study of vascularized free-draining intraperitoneal pancreatic segmental allografts in beagle dogs. J Clin Invest (1981) 0.78
Inhibition of gelatinase B (matrix metalloprotease-9) activity reduces cellular inflammation and restores function of transplanted pancreatic islets. Diabetes (2012) 0.78
Pancreas transplantation--registry report and a commentary. West J Med (1985) 0.77
Pancreatic Islet Cell Transplantation: A new era in transplantation. Can Fam Physician (1992) 0.75
Islet autotransplantation in a patient with hypercoagulable disorder. World J Transplant (2016) 0.75
Pancreatic transplantation. Br Med J (1980) 0.75
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med (1989) 4.40
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery (1967) 2.49
Transplantation of stomach, intestine, and pancreas: experimental and clinical observations. Surgery (1967) 2.49
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol (1997) 2.09
Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest (1985) 1.80
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg (1997) 1.79
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg (1996) 1.75
Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes (1975) 1.74
Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med (1992) 1.74
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet (1993) 1.70
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Hepatic resection for secondary neoplasms. Surgery (1982) 1.64
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation (1994) 1.58
Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity. Clin Exp Immunol (1974) 1.55
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med (1990) 1.53
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53
Pancreatitis and hyperparathyroidism. Br J Surg (1988) 1.52
Improved islet isolation from rat pancreas using 35% bovine serum albumin in combination with Dextran gradient separation. Transplantation (1996) 1.51
Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes (1992) 1.51
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Pancreas after kidney transplants. Am J Surg (2001) 1.44
Prolonged preservation increases surgical complications after pancreas transplants. Surgery (2000) 1.44
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44
Circadian variation in the rejection of rat kidney allografts. Surgery (1973) 1.43
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43
A rapid method for purification of large quantities of anti-lymphocytic serum. Proc Soc Exp Biol Med (1967) 1.42
Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N Engl J Med (1965) 1.42
Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41
Hyperglycemic nonketotic coma after liver transplantation. Arch Surg (1972) 1.40
The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med (1973) 1.40
First things first: laying the ethical and factual groundwork for living kidney donor selection standards. Am J Transplant (2008) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet (1988) 1.38
Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37